Search
Dasiglucagon
go.drugbank.com/drugs/DB15226ApprovedHypoglycemia is a common side effect of antidiabetic treatments, most notably insulin and sulfonylureas.
Sulfasalazine
go.drugbank.com/drugs/DB00795ApprovedInvestigationalHowever, sulfasalazine has less teratogenic side effects and faster onset of action compared to conventional DMARD.
Glasdegib
go.drugbank.com/drugs/DB11978ApprovedInvestigationalstandard of AML in older patients is still venetoclax with hypomethylation agents, new clinical combinations of glasdegib are being tested in hope of replacing venetoclax due to glasdegib's more favorable side
MB07811
go.drugbank.com/drugs/DB05192Investigationalcombination of selectivity for the beta form of the receptor, liver targeting and other structural characteristics that limit extra-hepatic activity is designed to provide significant efficacy while avoiding side
Rocatinlimab
go.drugbank.com/drugs/DB18809InvestigationalAdditionally, the diverse genetic backgrounds of patients may influence the drug’s effectiveness and side effects.[A263823]
Danazol
go.drugbank.com/drugs/DB01406ApprovedInvestigationalA synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used i...
ROX-888
go.drugbank.com/drugs/DB05364ExperimentalROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.
VGV-1
go.drugbank.com/drugs/DB05328ExperimentalVGV-1 is a potential salvage therapy for treatment of HIV infected people who have failed anti-retroviral therapy.
Lobeline
go.drugbank.com/drugs/DB05137InvestigationalAn alkaloid that has actions similar to nicotine on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, a...